Hématologie
Agenda
English e-section of Hématologie
Hématologie is the official organ of the French Society of Hematology. It publishes review articles in all areas of hematology, written by the best specialists in these fields. These reviews are generally solicited by members of the editorial board, but direct submissions are welcome. Regardless of the mode of submission, manuscripts are peer-reviewed and revisions are, in most cases, requested before publication. The journal also provides a forum for interns and junior faculty to comment on recent major publications or papers from international haematology meetings. The journal also publishes the proceedings of the annual meeting of the French Society of Hematology. Articles may be submitted in French or English.
It is intended for hematologists, as well as students in training (DES, AFSA, etc.). It covers all hematological diseases, both malignant and benign. Hématologie (Éditions John Libbey Eurotext) publishes, in French or in English, reviews, anatomical cases, forums for ethical reflection, recommendations from learned societies and cooperative groups, as well as short reports on current literature in haematology. It also features "Residents' Corner" and "How I treat", which give the floor to hematology residents and senior specialists respectively. Articles are most often solicited by the editorial staff, but any proposal for collaboration will be considered with interest.
Publication director
Gilles Cahn
Editor in chief
François Sigaux, Institut de Recherche Saint-Louis (IRSL), Université Paris Cité, Paris; INSERM U944/CNRS UMR7212, Paris; Saint-Louis Hospital, Hematology Laboratory, AP-HP, Paris
Assistant editors in chief
Mohamad Mohty, Department of Hematology, Saint Antoine Hospital, INSERM UMR 938, Sorbonne University, Paris
Olivier Bernard, U1170, Inserm, Gustave Roussy, Université Paris Diderot, Villejuif
Hervé Dombret, University Institute of Hematology, Saint-Louis Hospital, Paris
SFH representatives
Thierry Facon, President of the SFH
Olivier Bernard, SFH Scientific Affairs Delegate, President of the SFH Scientific Council
Mathilde Hunault, Vice-President of the SFH
Karim Laribi, member of the SFH Board of Directors
Editorial board
• Valérie Bardet, UFR Simone Veil Santé, Université Versailles-Saint Quentin-Paris Saclay, France
• Lucile Baseggio, Laboratoire d'hématologie cellulaire, GHS/Hospices civils de Lyon, Pierre-Bénite, France; Lymphoma Immuno-Biology Team, Faculty of Medicine de médecine Lyon-Sud, Pierre-Bénite, France; CytHem-SLP group.
• Ali Bazarbachi, American University of Beirut, Medical Center Beirut, Lebanon
• Christine Bellané-Chantelot, Department of Genetics, Pitié-Salpétrière Hospital, Inserm U1009, Institut Gustave-Roussy, Villejuif, France ; Intergroup myeloproliferative disorders
• Françoise Bernaudin, Club du globule rouge et du fer, Paris, France
• Dominique Bonnet, Senior Group Leader, Haematopoietic Stem cell Laboratory, Cancer Research UK, London Research Institute, London, Great Britain
• Eileen Boyle, NYU Langone Health Department, NewYork, USA
• Éolia Brissot, Clinical Hematology, Saint-Antoine Hospital, Paris, France
• Christine Chomienne, Cell Biology Department, Inserm UMRS 1131, University Institute of Haematology, Saint-Louis Hospital, Paris, France
• Sylvain Choquet, Clinical Haematology Department, Pitié-Salpêtrière Hospital, Paris
• Thomas Cluzeau, Head of Clinical Haematology Department, Nice University Hospital, Archet 1 Hospital, French Myelodysplasia Group
• Catherine Cordonnier, Clinical Haematology Department, Henri-Mondor Hospital, Créteil
• Yesim Dargaud, Clinical Haemostasis Unit, Louis Pradel Cardiology Hospital, EA4609, Claude Bernard Lyon 1 University, Lyon
• Éric Delabesse, Department of Haematology, University Hospital of Toulouse, Purpan Hospital, Toulouse
• Michel Delforge, Chairman Leuven Cancer Institute, Clinical Head Division of Hematology
• Virgine Éclache, Groupe francophone de cytogénétique hématologique
• Remi Favier, Biological Haematology Department, Reference Centre for Platelet Diseases, GHU Est Biology Unit, Armand Trousseau Hospital, Paris; Inserm U1009, Villejuif, Reference Centre for Platelet Diseases
• Pierre Fenaux, Clinical Haematology Department, Avicenne Hospital, Bobigny, France, French Myelodysplasia Group
• Pierre Fontana, Department of Angiology and Haemostasis, University Hospitals of Geneva, Switzerland
• Loïc Garçon, Biological Haematology Department, CHU Amiens-Picardie, Amiens; HEMATIM, EA 4666, Université Picardie Jules Verne, Amiens
• Irene Ghobrial, Longwood Center, Boston, Dana-Farber Cancer Institute, Boston
• Olivier Hermine, Adult Haematology Department, Necker-Enfants Malades Hospital, Paris; GR-Ex Laboratory, Biogenesis and pathologies of the red blood cell, Institute of Genetic Diseases (Imagine); Laboratory of molecular mechanisms of haematological disorders and therapeutic implications, Imagine, Inserm U1163
• Raphaël Itzykson, Inserm 2019, Institut Gustave-Roussy, Villejuif
• Dominique Jeaulmes, Francophone association for supportive cancer care
• Delphine Lebon, clinical haematology department, CHU Amiens
• Xavier Leleu, Clinical Haematology Department, CHU Poitiers, Francophone Myeloma Intergroup
• Florent Malard, Department of Clinical Haematology and Cellular Therapy, AP-HP, Hôpital Saint-Antoine, Inserm UMR 938, Paris
• Philippe Moreau, Department of Haematology, CHU de Nantes, Francophone Myeloma Intergroup
• Claude Preudhomme, haematology laboratory A, PM Degand biology and pathology centre, Lille, Group of molecular biologists of haematological malignancies
• Antoine Rauch, haemostasis-transfusion department, Lille University Hospital INSERM U1011, team 2
• Henri Rochant, former head of the haematology department, Henri-Mondor Hospital, Créteil
• Catherine Roche-Lestienne, France leukaemia intergroup
• Murielle Roussel, IUC-Oncopôle, Toulouse, France.
• Jean Soulier, Cytogenetics/Genomics Unit, Haematology Laboratory, Saint-Louis Hospital, Paris; Reference Centre for Constitutional Medullary Aplasia; Inserm U944, Genome and Cancer
• Xavier Troussard, Laboratory and Clinical Haematology Department, Caen Hospital, Caen, French Cellular Haematology Group and Chronic Lymphocytic Leukaemia Cooperative Group
Scientific board
Annelise Bennaceur, Yves Beuzard, Jean-Yves Cahn, Nicole Casadevall, Adrien Contejean, Regis Costello, Thierry de Revel, Philippe Gaulard, Robert Girot, Norbert Ifrah, Jérôme Larghro, Veronique Leblond, Albert Najman, Serge Pissard, Gerard Socié, Valérie Ugo, William Vainchenker, Bruno Varet.